UP!
|
Type
|
Public |
|---|---|
| Traded as | NASDAQ: SCMP |
| Industry | Pharmaceutical |
| Founded | 1996 |
| Headquarters | Bethesda, Maryland |
| Products | Amitiza |
| Website | sucampo |
Sucampo Pharmaceuticals, Inc. is a public, American biopharmaceutical company focused on medical applications of a class of ion channel modulators called prostones.
Sucampo has two marketed products, Amitiza and Rescula. As of 2014, Takeda distributes this drug globally except for in Japan and China.
The company's chief financial officer, as of 2014, was Cary J. Claiborne.
| 2016-07-12 | Reiterated Rating | Roth Capital | Buy | |
| 2016-07-11 | Reiterated Rating | Mizuho | Buy | |
| 2016-07-11 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-05 | Upgrade | WallachBeth Capital | Hold to Buy | $16.00 |
| 2016-05-04 | Reiterated Rating | Mizuho | Buy | |
| 2016-05-04 | Reiterated Rating | Guggenheim | Buy | $29.00 |
| 2016-05-01 | Reiterated Rating | Maxim Group | Buy | $26.00 |
| 2016-04-20 | Upgrade | Mizuho | Neutral to Buy | $14.00 |
| 2016-04-20 | Reiterated Rating | Roth Capital | Buy | |
| 2016-03-17 | Reiterated Rating | Leerink Swann | Market Perform | $17.00 |
| 2016-03-11 | Reiterated Rating | Leerink Swann | Hold | |
| 2016-03-10 | Reiterated Rating | WallachBeth Capital | Hold | $27.00 to $16.00 |
| 2016-03-09 | Lower Price Target | Leerink Swann | Market Perform | $20.00 to $17.00 |
| 2016-03-09 | Lower Price Target | Jefferies Group | Hold | $19.00 to $16.00 |
| 2016-03-09 | Boost Price Target | Maxim Group | Buy | $25.00 to $26.00 |
| 2016-03-09 | Reiterated Rating | Mizuho | Neutral | $14.00 |
| 2016-02-04 | Reiterated Rating | Mizuho | Neutral | $14.00 |
| 2016-01-16 | Reiterated Rating | Mizuho | Hold | |
| 2016-01-15 | Lower Price Target | Mizuho | Neutral | $19.00 to $14.00 |
| 2016-01-11 | Reiterated Rating | Maxim Group | Buy | $25.00 |
| 2015-11-20 | Initiated Coverage | Jefferies Group | Hold | $19.00 |
| 2015-11-13 | Reiterated Rating | Mizuho | Neutral | $22.00 to $19.00 |
| 2015-11-06 | Lower Price Target | HC Wainwright | $36.00 to $28.00 | |
| 2015-11-05 | Reiterated Rating | Mizuho | Neutral | $22.00 |
| 2015-10-29 | Initiated Coverage | Roth Capital | Buy | $29.00 |
| 2015-10-08 | Initiated Coverage | Mizuho | Neutral | $22.00 |
| 2015-09-03 | Initiated Coverage | Leerink Swann | Market Perform | $28.00 |
| 2015-08-27 | Boost Price Target | Guggenheim | Buy | $27.00 to $29.00 |
| 2015-08-27 | Boost Price Target | HC Wainwright | Buy | $31.00 to $36.00 |
| 2015-08-27 | Boost Price Target | WallachBeth Capital | Hold | $24.00 to $27.00 |
| 2015-08-26 | Reiterated Rating | Maxim Group | Buy | $25.00 |
| 2015-08-24 | Initiated Coverage | HC Wainwright | Buy | $31.00 |
| 2015-08-06 | Reiterated Rating | Guggenheim | Buy | $23.00 to $27.00 |
| 2015-08-06 | Boost Price Target | WallachBeth Capital | Hold | $19.00 to $24.00 |
| 2015-08-05 | Boost Price Target | Maxim Group | Buy | $20.00 to $25.00 |
| 2015-07-08 | Reiterated Rating | Maxim Group | Buy | $20.00 |
| 2015-05-07 | Boost Price Target | WallachBeth Capital | Buy to Hold | $18.00 to $19.00 |
| 2015-05-07 | Downgrade | Cantor Fitzgerald | Buy to Hold | $18.00 |
| 2015-04-06 | Initiated Coverage | Guggenheim | Buy | $23.00 |
| 2015-03-09 | Reiterated Rating | Cantor Fitzgerald | Buy | $18.00 |
| 2015-03-05 | Boost Price Target | WallachBeth Capital | Buy | $16.00 to $18.00 |
| 2015-03-02 | Downgrade | Credit Suisse | Neutral to Underperform | $10.00 to $13.00 |
| 2015-03-02 | Downgrade | Credit Suisse Group AG | Neutral to Underperform | $10.00 to $13.00 |
| 2015-02-23 | Set Price Target | Cantor Fitzgerald | Buy | $16.00 to $18.00 |
| 2015-01-20 | Set Price Target | Cantor Fitzgerald | Buy | $16.00 |
| 2015-01-20 | Boost Price Target | WallachBeth Capital | Buy | $12.00 to $16.00 |
| 2015-01-20 | Boost Price Target | Roth Capital | Buy | $18.00 to $20.00 |
| 2015-01-20 | Boost Price Target | Maxim Group | Buy | $15.00 to $19.00 |
| 2014-12-26 | Boost Price Target | Maxim Group | Buy | $14.00 to $15.00 |
| 2014-11-07 | Reiterated Rating | Cantor Fitzgerald | Buy | $14.00 to $16.00 |
| 2014-10-22 | Boost Price Target | Roth Capital | Buy | $9.00 to $18.00 |
| 2014-10-10 | Upgrade | Maxim Group | Hold to Buy | $7.00 to $10.00 |
| 2014-09-30 | Initiated | WallachBeth | Buy | $8 |
| 2014-09-30 | Initiated Coverage | WallachBeth Capital | Buy | $8.00 |
| 2014-08-01 | Initiated Coverage | Roth Capital | Buy | $9.00 |
| 2014-05-09 | Reiterated | MLV & Co | Buy | $14 to $11 |
| 2014-05-09 | Lower Price Target | MLV & Co. | Buy | $14.00 to $11.00 |
| 2013-11-07 | Lower Price Target | Cantor Fitzgerald | Buy | $11.00 to $10.00 |
| 2013-09-03 | Downgrade | Maxim Group | Buy to Hold | $9 to $7 |
| 2013-05-06 | Reiterated | Maxim Group | Buy | $10 to $12 |
| 2013-05-02 | Initiated | MLV & Co | Buy | $14 |
| 2013-03-19 | Initiated | Maxim Group | Buy | $10 |
| 2010-03-17 | Reiterated | Caris & Company | Buy | $10 to $8 |
| 2009-08-10 | Downgrade | Caris & Company | Buy to Above Average | $11 to $9 |
| 2009-02-23 | Reiterated | Credit Suisse | Neutral | $8 to $7 |
| 2008-11-11 | Initiated | Credit Suisse | Neutral | $10 |
| 2008-09-25 | Initiated | Caris & Company | Buy | $15 |
| 2016-07-12 | Reiterated Rating | Roth Capital | Buy | |
| 2016-07-11 | Reiterated Rating | Mizuho | Buy | |
| 2016-07-11 | Reiterated Rating | Maxim Group | Buy | |
| 2016-05-05 | Upgrade | WallachBeth Capital | Hold to Buy | $16.00 |
| 2016-05-04 | Reiterated Rating | Mizuho | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SCMP 15 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 1.39M |
| BlackRock Institutional Trust Company, N.A. | 0.73M |
| RUSSELL FRANK CO/ | 0.23M |
| EverPoint Asset Management, LLC | 0.21M |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 0.11M |
| BLACKROCK ADVISORS LLC | 0.11M |
| BlackRock Investment Management, LLC | 91906 |
| FolioMetrix LLC | 61800 |
| MetLife Securities, Inc | 60461 |
| BlackRock Group LTD | 21651 |
| CAPSTONE ASSET MANAGEMENT CO | 12360 |
| Nine Chapters Capital Management LLC | 10800 |
| VTL Associates, LLC | 762 |
| HERNDON CAPITAL MANAGEMENT LLC | 458 |
| BlackRock Japan Co. Ltd | 162 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Donley Matthew Maxwell Exec. V.P., Human Resources | 0.08% (36975) | SCMP / |
| MAUDLIN TIMOTHY I | 0.07% (32870) | SCMP / WWWW / |
| Edick Paul R | 0.04% (19830) | DRTX / NEOS / NLNK / PDLI / SCMP / |
| Spiegel Robert J. | 0.03% (14930) | CAPS / GERN / PTCT / SCMP / |
| Getman Daniel P | 0.02% (9800) | SCMP / |
| Greenleaf Peter Chief Executive Officer | 0.01% (4792) | MSTX / SCMP / |
| Alder Matthias EVP, Business Dev. & Licensing | 0.01% (4763) | SCMP / |
| Claiborne Cary J Chief Financial Officer | 0.01% (2864) | SCMP / |
UM